IMARC Group’s latest report, titled “Preventive Healthcare Technologies and Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” finds that the global preventive healthcare technologies and services market is expected to exhibit a CAGR of 13.20% during the forecast period (2023-2028). Preventive healthcare technologies and services comprise early detection and screening, prevention, chronic disease management, vaccines, and advanced technologies to minimize errors. They are used to measure daily health parameters, including blood oxygen saturation, blood pressure, heart rate, and sleep patterns. They are used by healthcare professionals to identify future illnesses and treatments. They also assist in screening, check-ups, and patient counseling to detect and prevent various health problems at an early stage. They also reduce the risks of developing severe chronic diseases, including cardiovascular diseases (CVDs), diabetes, cancer, hypertension, respiratory ailments, and other contagious infections. Preventive healthcare technologies and services help eradicate, eliminate, and minimize the negative impact of various diseases.
Global Preventive Healthcare Technologies and Services Market Trends:
The increasing prevalence of chronic diseases and viral infections and the rising aging population, which is more prone to such severe medical conditions, are among the major factors driving the demand for preventive healthcare technologies and services around the world. Moreover, the growing adoption of wearable devices, including fitness trackers and fitness bands, which can be connected to smart devices for collecting patient data in real time, is favoring the market growth. In addition, the integration of artificial intelligence (AI) and cloud-based solutions in preventive healthcare technologies and services to identify and predict diseases and provide personalized and accurate assumptions and treatment methods based on the history of the patient. Apart from this, governments of several countries are undertaking initiatives to support vaccination programs for improving life expectancy. This, coupled with the growing public awareness about preventive methods, is creating a positive outlook for the market. Furthermore, significant improvements in the healthcare infrastructure are anticipated to provide a favorable market outlook.
- Based on the type, the market has been classified as early detection and screening, vaccines, chronic disease management, and advanced technologies to reduce errors. Early detection and screening currently hold the largest market share.
- Based on the application, the market has been categorized into hospitals, clinics, and others. Hospitals account for the majority of the total market share.
- Region-wise, the market has been divided into North America (United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. Amongst these, North America dominates the market. Amongst these, North America dominates the market.
- The competitive landscape of the market has also been analyzed, with some of the key players being Abbott Laboratories, GlaxoSmithKline PLC, McKesson Corporation, Medtronic PLC, Merck & Co. Inc., Myriad Genetics, Inc., Omron Healthcare Inc., Pfizer Inc., Quest Diagnostics, and Sanofi S.A.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800